Catalent
CTLT
#1819
Rank
ยฃ8.60 B
Marketcap
ยฃ47.42
Share price
0.00%
Change (1 day)
11.79%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

EPS for Catalent (CTLT)

EPS in 2023 (TTM): -ยฃ1.03

According to Catalent's latest financial reports the company's current EPS (TTM) is -ยฃ4.73. In 2022 the company made an earnings per share (EPS) of ยฃ1.70 a decrease over its 2021 EPS that were of ยฃ2.44.

EPS history for Catalent from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-ยฃ1.03-160.52%
2022ยฃ1.70-30.58%
2021ยฃ2.4479.67%
2020ยฃ1.36114.12%
2019ยฃ0.63-15%
2018ยฃ0.7575.44%
2017ยฃ0.43-22.97%
2016ยฃ0.55-59.56%
2015ยฃ1.37282.05%
2014ยฃ0.36-378.2%
2013-ยฃ0.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Supernus Pharmaceuticals
SUPN
-ยฃ1.43-69.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
ยฃ11.39-340.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Aerie Pharmaceuticals
AERI
-ยฃ0.56-88.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
-ยฃ1.11-76.62%๐Ÿ‡บ๐Ÿ‡ธ USA